Obesity treatments including GLP-1 medications provide significant weight loss and health improvements but are costly and often not sustained by patients. Often, up to half of patients discontinue therapy within six months due to factors such as insurance coverage issues, supply shortages, complex authorization processes, and side effects. To maximize ROI, organizations need to find comprehensive solutions that provide personalized, alternative and supportive treatments, and streamline administrative processes.
‘Matrix’ Hackers Deploy Massive New IoT Botnet for DDoS Attacks
Aqua Nautilus researchers have found a new large-scale Distributed Denial of Services (DDoS) campaign, launched by threat actor Matrix, which targets a network of Internet-connected
